Access cutting-edge stroke treatment through this clinical trial at a research site in Augusta. Study-provided care at no cost to qualified participants.
Access stroke specialists in Augusta at no cost
This study follows strict safety protocols and ethical guidelines
All study-related stroke treatment provided free
The purpose of this study is to evaluate the efficacy and safety of redasemtide in adult participants with acute ischemic stroke (AIS). This study consists of 2 cohorts, Cohort A and Cohort B. Cohort A (redasemtide or placebo) will enroll participants who are ineligible for systemic thrombolysis and/or mechanical recanalization therapy. Cohort B (redasemtide or placebo) will enroll participants who are eligible to receive or who have received systemic thrombolysis and/or mechanical recanalizatio
Sponsor: Shionogi
Check if you qualify for this stroke clinical trial in Augusta, GA
If you're searching for stroke treatment options in Augusta, GA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Augusta research site is actively enrolling participants for this clinical trial. You'll receive care from experienced stroke specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.